Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Solid Tumors”

5,435 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,435 results

Early research (Phase 1)Looking for participantsNCT02998567
What this trial is testing

Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Who this might be right for
Non Small Cell Lung Cancer
Royal Marsden NHS Foundation Trust 60
Early research (Phase 1)Study completedNCT05400265
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Who this might be right for
Adult Solid Tumor
Shanghai Henlius Biotech 9
Not applicableNo Longer AvailableNCT03420430
What this trial is testing

Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care

Who this might be right for
Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)Acute Myeloid Leukemia (6 Patients)
Genelux Corporation
Early research (Phase 1)Study completedNCT00243100
What this trial is testing

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT04345900
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 55
Early research (Phase 1)UnknownNCT01226407
What this trial is testing

Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile

Who this might be right for
Solid Tumour
CrystalGenomics, Inc. 36
Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT05378737
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Who this might be right for
Advanced Solid Tumors
Bio-Thera Solutions 216
Early research (Phase 1)Active Not RecruitingNCT05174637
What this trial is testing

FDA018-ADC in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Early research (Phase 1)UnknownNCT03662815
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Early research (Phase 1)Study completedNCT00095160
What this trial is testing

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04632108
What this trial is testing

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Malignant Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 199
Early research (Phase 1)Study completedNCT02719691
What this trial is testing

Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerSolid Tumors
University of Colorado, Denver 47
Early research (Phase 1)Ended earlyNCT04168320
What this trial is testing

SBRT-based PArtial Tumor Irradiation of HYpoxic Segment

Who this might be right for
Bystander EffectAbscopal EffectUnresectable Malignant Solid Neoplasm+1 more
Klinikum Klagenfurt am Wörthersee 30
Not applicableActive Not RecruitingNCT04650178
What this trial is testing

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 274
Early research (Phase 1)Looking for participantsNCT07368478
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Biocity Biopharmaceutics Co., Ltd. 180
Early research (Phase 1)Looking for participantsNCT06640413
What this trial is testing

Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors

Who this might be right for
FAP
Philogen S.p.A. 56
Load More Results